SCHEMBL6199723

SCHEMBL6199723

C#Cc1cccc2c1NCCNC2=O

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 13/20 0.41
▸ PARP10 Q53GL7 4/20 0.41
▸ PARP11 Q9NR21 4/20 0.41
▸ PDPK1 O15530 1/20 0.41
▸ MAPT P10636 1/20 0.40
▸ GRM5 P41594 1/20 0.36
▸ CA12 O43570 1/20 0.35
▸ CA9 Q16790 1/20 0.35
▸ PIM1 P11309 1/20 0.35
▸ CSNK1A1 P48729 1/20 0.35
▸ CDK5 Q00535 1/20 0.35
▸ ROCK1 Q13464 1/20 0.35
▸ DYRK1A Q13627 1/20 0.35
▸ LRRK2 Q5S007 1/20 0.35
▸ CLK4 Q9HAZ1 1/20 0.35
▸ DYRK1B Q9Y463 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5071984 0.78 PARP1 (0.58) PARP1PARP10PARP11PDPK1PIM1
SCHEMBL6200526 0.78 GRM5 (0.50) PARP1PARP10PARP11PDPK1MAPT
SCHEMBL6199173 0.74 GRM5 (0.47) PARP1PARP10PARP11MAPTGRM5
SCHEMBL6198918 0.74 GRM5 (0.52) PARP1PARP10GRM5
SCHEMBL6203539 0.73 PARP10 (0.41) PARP1PARP10PARP11GRM5PIM1
SCHEMBL6195383 0.73 GRM5 (0.41) PARP1PARP10PARP11PDPK1GRM5
SCHEMBL6198768 0.73 PARP1 (0.46) PARP1PARP10PARP11PDPK1MAPT
SCHEMBL12750356 0.73 PARP1 (0.61) PARP1PARP10PARP11PDPK1MAPT
SCHEMBL1346861 0.73 PARP1 (0.44) PARP1PARP10PARP11PDPK1MAPT
SCHEMBL6202358 0.72 GRM5 (0.40) PARP1PARP10PARP11PDPK1GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1208104-B1 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMA (US) 2005-01-19 — — EP disclosed
US-6548494-B1 3,4-dihydro-2H-(1,4)diazepino(6,7,1-hi)indol-1-one or 1-thione derivatives where indole C3 could also be N; use treating cancers as well as stroke, head trauma, and neurodegenerative diseases AGOURON PHARMACEUTICALS, INC. 2003-04-15 — — US disclosed
EP-1208104-A2 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMACEUTICALS, INC. (US) 2002-05-29 — — EP disclosed
WO-2001016136-A2 TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES AGOURON PHARMACEUTICALS, INC. (US) 2001-03-08 — — WO disclosed
Send feedback